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Complement factor D is a serine protease essential for the
activation of the alternative pathway and is expressed in the
kidney, adipocytes, and macrophages. Factor D is found at
relatively high levels in glomeruli suggesting that this
component of the complement cascade could influence renal
pathophysiology. In this study, we utilize mice with a
targeted deletion of the activating complement factor D
gene and compare these results to mice with targeted
deletion of the inhibitory complement factor H gene.
Eight-month-old mice with a deleted factor D gene
spontaneously develop albuminuria and have reduced
creatinine clearance due to mesangial immune complex
glomerulonephritis. These mesangial deposits contain C3 and
IgM. In contrast to the mesangial location of the immune
deposits in the factor D-deficient mice, age-matched factor H-
deficient mice develop immune deposits along the
glomerular capillary wall. Our observations suggest that
complement factor D or alternative pathway activation is
needed to prevent spontaneous accumulation of C3 and IgM
deposits within the mesangium. Our studies show that the
complement factor D gene knockout mice are a novel model
of spontaneous mesangial immune complex
glomerulonephritis.
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The complement system can be activated by the classical,
lectin, or alternative pathways to generate ‘convertases’,
enzyme complexes that cleave C3 and C5, leading to the
formation of biologically active proteins, including anaphy-
latoxins (C3a and C5a), opsonic fragments (C4b, C3b, and
iC3b) and the membrane attack complex (C5b-9).1 Together
these activated proteins mediate the biologically important
functions of complement including host defense (opsoniza-
tion, leukocyte activation, and target cell lysis), immune
complex clearance, and an accessory role in antibody
production, through its role as a natural adjuvant.
Factor D is a highly specific serine protease that is essential
for alternative pathway activation.2 Activated C3, formed
either spontaneously through hydrolysis of the internal
thioester bond (C3i) or enzymatically by the C3 convertase
complexes (C3b) interacts with the complement protein
factor B. Factor B bound to activated C3 is cleaved by factor
D releasing a 20 kDa activation fragment (Ba).3 The larger
factor B fragment (Bb) remains bound to activated C3 and
this complex represents the alternative pathway C3 con-
vertase (C3iBb, C3bBb). Thus, in the absence of factor D
cleavage of factor B bound to activated C3 does not occur,
preventing alternative pathway C3 convertase formation. In
contrast, factor H is the major fluid-phase inhibitory protein
of alternative pathway activation. Its critical role in down-
regulating alternative pathway activation is illustrated by the
observation that individuals with genetic deficiency of factor
H develop secondary markedly reduced plasma C3 levels due
to C3 consumption as a consequence of uncontrolled
spontaneous alternative pathway activation. Both thrombotic
microangiopathy and membranoproliferative glomerulone-
phritis type II (MPGN type II, also termed dense deposit
disease) have been reported in association with factor H
dysfunction.4 Notably, complete deficiency of this protein is
usually associated with MPGN type II, whereas thrombotic
microangiopathy is generally associated with mutations that
specifically target surface recognition domains of the
protein.4
Factor D is expressed at relatively high levels in glomeruli,5
suggesting that local synthesis of this complement compo-
nent may play a role in renal function. To determine whether
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factor D has a physiological relevant role within the kidney,
we have studied the spontaneous renal phenotype of 8-
month-old gene-targeted factor D-deficient mice (Cfd/,6).
We compared the renal pathology of these animals with the
spontaneous pathology that develops in factor H-deficient
mice (Cfh/,7). Thus, analysis of these two mutant strains
enabled us to contrast the spontaneous renal histological
changes that develop when alternative pathway activation is
either prevented (Cfd/) or uncontrolled (Cfh/). Our
data demonstrated that C57BL/6 Cfd/ mice developed
extensive immune deposits within the mesangium while the
spontaneous immune deposits that develop in the Cfh/
animals were located along the capillary walls.
RESULTS
Genotyping and reverse transcriptase-polymerase chain
reaction
Polymerase chain reaction (PCR) amplification in wild-type
(WT) controls generated the expected 500 bp amplified
product, whereas in both Cfh/ and Cfd/ mutant mice a
400 bp product was obtained (Figure 1). There was no
expression of the factor H gene in the kidneys or liver of the
Cfh/ mutants, and renal expression of Factor D was absent
in the Cfd/ mutants (Figure 2). In both homozygous
mutants, expression of C3 in the kidney and liver was
increased as compared with WT controls (Figure 2).
Renal function
The findings are summarized in Table 1. Both Cfd/ and
Cfh/ mutant mice had decreased creatinine clearance and
significant albuminuria when compared with WT controls
(Po0.05), the decline in renal function was greater in the
Cfh/ mutants.
Glomerular lesions
Cfd/ mice develop mild mesangial expansion Light microscopy.
Glomeruli in Cfd/ mice show mild mesangial expansion with
an increase in mesangial matrix and mild increase in cellularity
(Figure 3b) as compared with WT mice (Figure 3a). The
increase in mesangial cellularity was due to mild increase in
mononuclear cells. On average, there were 31 cells (73.0) per
glomerulus in the Cfd/ mice, whereas WT mice contained 25
cells (71.5) per glomerulus. The mesangial cells in the Cfd/
mice stained for predominantly for smooth muscle actin
(Figure 4b), whereas they were negative for F4/80 (Figure 4e),
indicating that the increase in cellularity was due to mesangial
cell proliferation and not infiltrating mononuclear leukocytes.
Glomerular capillaries did not show significant changes, and in
particular, endocapillary proliferation or formation of double
contours along the capillary walls was absent. Segmental and
global glomerulosclerosis was not present, and neither was there
significant tubulointerstitial disease. Isolated tubules contained
red blood cells.
Cfh –/–  +/+  +/+  Cfd –/–
500 bp
400 bp
Figure 1 | Genotyping of wild-type, Cfh/, and Cfd/ mice.
Genotyping of Cfh/ and WT mouse. 500 bp band corresponds to
the WT sequence, whereas the 400 bp corresponds to the disrupted
sequence of exon 3 of factor H gene. Genotyping of Cfd/ and
WT mouse. 500 bp band corresponds to the WT sequence, whereas
the 400 bp corresponds to the disrupted sequence of exon 3 of
factor D gene.
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Figure 2 | RT–PCR of WT, Cfh/, and Cfd/ kidney and liver
tissues. Glyceraldehyde 3-phosphate was used as a control.
Table 1 | Renal function analysis of Cfh/, Cfd/, and WT mice
Mouse
Weight
(g)
24 h urine volume
(ml)
Serum creatinine
(mg/dl)
Urine creatinine
(mg/dl)
Urine albumin
(mg/dl)
Creatinine clearance
(ml/24 h)
Cfh/ (n=6) 30.33 1.00 0.6470.08 4.8970.87 597794 (P=0.0004*) 7.3571.08 (P=0.0005*)
Cfd/ (n=5) 29.6 1.00 0.7470.21 5.8670.90 349794 (P=0.019*) 8.5873.07 (P=0.023*)
WT (n=5) 30 1.00 0.5170.22 6.7470.66 153758 17.3375.33
SEM, standard error of mean, WT, wild-type.
Values are in mean7SEM.
*Po0.05 Cfh or Cfd vs WT.
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Glomeruli in Cfh/ mice were hypercellular (Figure 3c).
The mesangium was expanded with increased cellularity
primarily due to mononuclear cells. A few glomerular
capillaries showed endocapillary proliferation due to mono-
nuclear cells, and glomerular tufts had a distinctly lobular
appearance. On average, there were 40 cells (75.2) per
glomerulus. Again, the mesangial cells stained for smooth
muscle actin (Figure 4c), whereas they were negative for
F4/80 (Figure 4f), indicating that they were mesangial cells
and not infiltrating mononuclear leukocytes. Glomerular
capillary walls were thickened and new basement membrane
formation could be seen resulting in double contour
formation. Segmental sclerosis was also noted. Significant
tubulointerstitial disease was not present (Table 2).
Cfd/ mice show marked mesangial C3 and IgM accumula-
tion Immunofluorescence microscopy. Glomeruli in Cfd/
mice showed marked granular staining for C3 (3þ ) and IgM
(3þ ) (Figure 5c and d) in the mesangium compared with
WT mice (Figure 5a and b). There was also mild mesangial
staining for IgG (1–2þ ) and IgA (þ /), but virtually no C3
or other immune deposits along the glomerular capillary
walls. In contrast, glomeruli in Cfh/ mice showed marked
granular staining for C3 and IgM predominantly along
glomerular capillary walls (Figure 5e and f). There was also
mild positive staining for IgG (1–2þ ) and IgA (trace) along
the capillary walls.
Cfd/ mice show accumulation of mesangial electron-dense
deposits Electron microscopy. WT mice showed normal
appearing mesangium and glomerular capillary walls.
Electron-dense deposits were not present in the mesangium
or along the capillary walls (Figure 6a). Ultrastructural
examination of glomeruli of Cfd/ mice showed mesangial
expansion with an accumulation of electron-dense deposits
(Figure 6b–d), which were mesangial and paramesangial in
location. In comparison, Cfh/ mice showed changes of
membranoproliferative glomerulonephritis with subendo-
thelial expansion by basement membrane material, cellular
debris and scattered deposits resulting in double-contour
b
c
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Figure 3 | Light microscopy showing glomerular lesions. (a) WT
mice, (b) Cfd/mice, and (c) Cfh/mice. Glomeruli from Cfd/ mice
show mild mesangial expansion with mild increase in mesangial
cellularity. On the other hand, glomeruli from Cfh/ mice show
features of membranoproliferative glomerulonephritis (periodic acid
Schiff stain  60).
a b cCfd –/–
Cfd –/– Cfh –/–
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e fd Wild type
Wild type
Figure 4 | Immunoperoxidase stains for smooth muscle actin and F4/80. (a) WT mice, (b) Cfd/mice, and (c) Cfh/mice; and F4/80 in (d)
WT mice, (e) Cfd/mice, and (f) Cfh/mice. Glomeruli from Cfd/ and Cfh/mice show increase in mesangial cells that stain for smooth
muscle actin compared with WT mice, whereas there is no significant mesangial staining for F4/80 in any of the groups.
Table 2 | Comparison of glomerular findings in WT, Cfd/ mice, and Cfh/ mice
WT Cfd/ Cfh/
Light microscopy Normal Mild-to-moderate mesangial expansion Membranoproliferative glomerulonephritis
Immunofluorescence microscopy No immune complexes Mesangial C3 and IgM Capillary wall C3 and IgM
Electron microscopy No electron-dense deposits Mesangial electron-dense deposits Capillary wall electron-dense deposits
WT, wild-type.
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formation (Figure 6e). Scattered subepithelial, intramem-
branous, and subendothelial deposits occurred along the
glomerular capillary walls. Segmental endocapillary prolif-
eration by mononuclear cells was also present (Figure 6f).
DISCUSSION
The complement alternative pathway plays an important role
in the development and regulation of glomerular and
tubulointerstitial disease. Specifically, this pathway contri-
butes to the proliferative glomerulonephritis that develops in
MRL/lpr mice. Hence, MRL/lpr mice deficient in either factor
B8 or factor D9 showed protection against the development of
glomerulonephritis in comparison to complement-sufficient
MRL/lpr mice. Uncontrolled alternative pathway activation
due to deficiency of factor H results in MPGN type II in
humans,10 pigs,11 and mice.7 Activation of the alternative
pathway is also required for tubulointerstitial injury to
develop following ischemia–reperfusion injury as evidenced
by the demonstration that mice deficient in factor B12 or WT
mice treated with an anti-factor B antibody13 show protec-
tion against tubulointerstitial damage following ischemia–
reperfusion injury.
Because Factor D is an essential component of the
alternative pathway, we investigated the renal consequences
of deficiency of this protein. Cfd/ mutant mice develop
extensive mesangial immune deposits that stain predomi-
nantly for C3 and IgM. The deposits are present in the
mesangium and there is mild mesangial expansion with mild
mesangial proliferative features. Our data show that the
increase in mesangial cellularity is due to mesangial cell
a b c
d e f
A. WT
Figure 6 | Electron microscopy showing glomerular lesions. (a) WT mice. (b–d) Cfd/ mice show mesangial electron-dense deposits. (e and
f) Cfh/ mice show scattered deposits along the capillary walls with double-contour formation. Arrows point at electron-dense deposits.
a b c
d e f
C3: WT IgM: WT C3: cfd –/–
C3: cfh –/– IgM: cfh –/–IgM: cfd –/–
Figure 5 | Direct immunofluorescence microscopy for C3 and IgM. (a and b) WT mice show mild or no C3 or IgM deposition. (c and d) Cfd/
mice show marked mesangial C3 and IgM deposition. (e and f) Cfh/mice show granular C3 and IgM along the capillary walls.
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proliferation rather than infiltration by extrinsic cells.
Immune deposits are absent along glomerular capillary walls.
These findings are in sharp contrast to those in mice deficient
in factor H, where immune deposits develop along
glomerular capillary walls in association with significant
proliferative changes as reported previously.7,14
Several components of complement are expressed in the
kidney. Cfd and properdin are expressed at relatively high
levels in glomeruli, whereas factor B expression is signifi-
cantly greater in the medulla.5,15 Components C2, C3, and
C4 and factor H are expressed predominantly in cortical
tubule-rich fractions. These differences raise the possibility
that there are differing roles for the alternative pathway (AP)
and classical complement pathways in different regions
within the kidney,5 and also suggest that factor D may play
a role in local glomerular activation of the AP. Consistent
with this hypothesis, we found that factor D deficiency is
associated with localized alteration of the AP of complement
resulting in glomerular complement and immune deposition.
The renal lesions in Cfd/ mice are restricted to the
mesangium and are reminiscent of lesions seen in systemic
lupus (mesangial lupus nephritis, WHO Class II) raising the
possibility that there maybe an autoantibody response in
Cfd/ mice. Also, antinuclear autoimmunity has previously
been noted in (129/SvC57BL/6) mice. Bygrave et al.16 have
shown that a 129/Sv interval on chromosome 1 in otherwise
completely C57BL/6 genome will drive autoimmunity, that is
antinuclear antibodies. Similarly, spontaneous nephritis can
be driven by a 129Sv interval on chromosome 7 on the
C57BL/6 genome.17 In our study, the Cfd/ mice have been
backcrossed onto C57BL/6 but still carry the 129/Sv interval
around the targeted locus. It is unlikely that the mesangial
deposits present in Cfd/ mice are due to autoimmunity,
because the factor D gene is on chromosome 10, which to our
knowledge is not linked with autoimmunity.
It should be kept in mind that mesangial immune deposits
are usually slow to develop and do not elicit the same
inflammatory response as subendothelial deposits. Although
mesangial deposits were noted at 4 months in Cfd/ mutant
mice (data not shown), we followed Cfd/ mutant mice for
8 months for better identification and confirmation of the
mesangial deposits. In particular, Cfd/ mice may serve as a
model for mesangial immune complex glomerulonephritis.
There are only few models of mesangial immune complex
disease in the literature, and these usually involve treatment
of mice with various agents such as mercury,18 mycotoxin
deoxynivalenol,19 or even intravenous injection of immune
complexes.20
Our findings are somewhat surprising because deficiency
of factor D would be predicted to inhibit complement
activation due to decreased C3 convertase generation thereby
preventing immune deposition in glomeruli. However,
restriction of the immune deposits to the mesangium
suggests that there is a localized protective effect of factor
D. We also found that Cfdþ / mice develop some degree of
mesangial deposits, although the findings are not consistent
(data not shown). Possible explanations for our findings
include firstly that the absence of factor D prevents intact C3
cleavage following alternative pathway activation or tick-over
activation (autoactivation), and hence intact C3 accumulates
at sites of synthesis, for example mesangial cells and
hepatocytes. Consistent with this possibility, we found
increased C3 both in the kidney and liver. Over time, this
increase is harmful in the kidney, resulting in mesangial cell
injury and a proliferative response (increase in mesangial
matrix and increase in mesangial cells). It is also possible that
lack of iC3b production in Cfd/ mice leads to negative
feedback and increased C3 synthesis. Higher circulating C3
levels6 presumably can cause greater C3-mediated injury to
cells following immunoglobulin binding. Defining the nature
of the C3 (intact C3, C3b, iC3b, and C3c) in the mesangium
will shed more information on the mechanism of factor D
deficiency-induced mesangial C3 and immune deposits.
Second, the alternative pathway is known to be necessary
for the solubilization of preformed large immune com-
plexes.21 This process presumably occurs after tissue deposi-
tion of immune complexes and results in covalent binding
of C3 to the immune complex lattice, which leads to
their solubilization. In the absence of factor D, the altern-
ative pathway is unable to solubilize mesangial immune
complexes.
Factor D deficiency has been reported in one family with a
history of Neisseria meningitides infection.22 One affected
family member also developed renal failure, although this
was likely due to sepsis and acute tubular necrosis. Renal
biopsy was not done. In summary, our analysis demonstrates
that murine factor D deficiency provides a novel model of
mesangial immune complex glomerulonephritis. Further
studies are now required to understand the mechanism
through which factor D deficiency results in mesangial
disease.
MATERIALS AND METHODS
Animals
For this study, 8-month-old C57BL/6 factor D-deficient mice (Cfd/;
n¼ 5, three males and two females), C57BL/6 factor H-deficient
mice (Cfh/; n¼ 6, three males and three females), and C57BL/6
WT mice (WT; n¼ 5, two males and three females) were used.
All procedures were approved by the University Animal Care and
Use Committee (UACUC) of the University of Iowa. WT, Cfd/,
and Cfh/ mice were obtained6,7 and backcrossed on to a C57BL/6
background for several generations. Identification of mouse
genotypes were done using PCR as described.6,7 DNA was extracted
from mouse tail snips using the DNeasy Tissue Kit (Qiagen,
Valencia, CA, USA). PCR amplification at 551C annealing time for
35 cycles resulted in either a 500 bp WT sequence or 400 bp insert
sequence which corresponds to the disrupted sequence of exon 3 of
factor H gene or factor D gene (Figure 1).
RT–PCR. Expression patterns of factor H, factor D, and C3 were
determined in mouse kidney and liver tissues using reverse
transcriptase (RT)–PCR. Most complement factors are primarily
produced in the liver except for factor D, which is produced in fat
cells. RNA was extracted from mouse tissues using the Protein and
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RNA Isolation System (PARIS; Ambion). RT–PCR was carried out
using the Advantage RT-for-PCR (BD Biosciences, Foster City, CA,
USA). Specific primers flanking the targeted deletion for factor H
and factor D genes were used for PCR (factor H forward:
CTCCTGGTCAGAACAACTATATCCAG; factor H reverse: AGTTC
TGTCACAGGTAGACACTTCAC; factor D forward: CTGA
CAGCCTTGAGGACGACCTCATTC; factor D reverse: CACACAT
CATGTTAATGGTGACTACC). Primers for C3 were also generated
(forward: CACTCACGTAGTGACATGGTAGAGG; reverse:
CTAGCTCCAATCAGGGTGTAGTAAGC) GAPDH expression was
used as a control. RT–PCR studies were performed three times. The
data shown in Figure 2 are representative.
Renal function
Mice were housed in individual metabolic cages before being killed
to collect 24-h urine samples. At the time of killing, blood was
obtained to assess renal function by measuring plasma creatinine
and albumin; urinary creatinine and albumin were also measured
(QuantiChromTM Creatinine and BCP Albumin Assay Kits, Bio-
Assays Systems, Hayward, CA, USA). Creatinine clearance was used
as an index of glomerular filtration rate and was calculated by the
following formula: Creatinine clearance¼ (urinary creatinine
urine volume)/serum creatinine.
Histological studies
Mice were killed with pentobarbital (150 mg/kg intraperitoneally)
followed by cervical dislocation. Kidneys were preserved in 10%
formaldehyde for light microscopy, with the exception of the poles
of the kidneys, which were preserved in 2.5% glutraldehyde for
ultrastructural analyses by electron microscopy. A portion of each
kidney was also snap-frozen for immunofluorescence studies.
Light microscopy. Formalin-fixed tissue was embedded in
paraffin and 4 mM sections were stained with hematoxylin and
eosin, periodic acid Schiff, and silver stain for histological analysis.
The total number of nucleated cells in a glomerulus was counted.
This included endothelial cells, mesangial cells, visceral epithelial
cells, and any infiltrating cells. For each mouse kidney section, at
least 20 glomeruli were available for counting. The total number of
cells counted was divided by the total number of glomeruli counted
to yield the average number of cells/glomerulus. Immunochemical
staining on paraffin sections using antibodies to mouse smooth
muscle actin (Dako Corporation, Carpinteria, CA, USA) to identify
mesangial cells, and F4/80 (Sigma, St Louis, MO, USA) to identify
monocytes/macrophages, was performed by standard staining
techniques.
Immunofluorescence microscopy. Renal tissue was snap-
frozen and embedded in Tissue Tek OCT (Miles Inc, Elkhart, IN,
USA). Sections of 4 mM were cut and direct immunofluorescence
studies were done using fluorescein isothiocynate-conjugated sheep
antibody against IgM, IgG, IgA, and C3c (Sigma; and Binding Site,
CA, USA).
Electron microscopy. Semithin (1 mM) sections were stained
with toluidine blue and examined. Ultrathin sections were stained
with uranyl acetate and lead citrate, and examined using Jeol 100S
electron microscope.
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